CasNo.755037-03-7,Regorafenib,(755037-03-7) Suppliers

0 Metric Ton	Negotiable

Min.Order :0 Metric Ton
Purity: 98% min

Keywords

Regorafenib BAY 73-4506; BAY73-4506 755037-03-7

Quick Details

Appearance:
Application:Regorafenib (BAY 73-4506) is a multi-target inhibitor for VEGFR1, VEGFR2, VEGFR3, PDGFRβ, Kit, RET and Raf-1 with IC50 of 13 nM/4.2 nM/46 nM, 22 nM, 7 nM, 1.5 nM and 2.5 nM, respectively. IC50 value:
PackAge:10mg;50mg;100mg
ProductionCapacity:50-100|Metric Ton|Day
Storage:-20℃
Transportation:

Superiority:

Regorafenib

RegorafenibRegorafenib (BAY 73-4506) is a multi-target inhibitor for VEGFR1, VEGFR2, VEGFR3, PDGFRβ, Kit, RET and Raf-1 with IC50 of 13 nM/4.2 nM/46 nM, 22 nM, 7 nM, 1.5 nM and 2.5 nM, respectively. IC50 value: Target: VEGFR; Raf; PDGFRβ in vitro: Regorafenib strongly prevents VEGFR2 autophosphorylation in NIH-3T3/VEGFR2 cells with IC50 of 3 nM.

url：www.medchemexpress.cn/regorafenib.html

Details:

Regorafenib

RegorafenibRegorafenib (BAY 73-4506) is a multi-target inhibitor for VEGFR1, VEGFR2, VEGFR3, PDGFRβ, Kit, RET and Raf-1 with IC50 of 13 nM/4.2 nM/46 nM, 22 nM, 7 nM, 1.5 nM and 2.5 nM, respectively. IC50 value: Target: VEGFR; Raf; PDGFRβ in vitro: Regorafenib strongly prevents VEGFR2 autophosphorylation in NIH-3T3/VEGFR2 cells with IC50 of 3 nM.

url：www.medchemexpress.cn/regorafenib.html